Why movement disorders should be a formally acknowledged subspecialty of neurology editorial by Dirk Dressler, Ivan Milanov

“…He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. IM: The development of medicine: Since the last century medicine has expanded tremendously in almost every aspect: in its scientific basis, in its diagnostic opportunities, in its therapeutic armamentarium and in its financial basis. …”
Get full text